PP
EVH icon

PDT Partners’s Evolent Health EVH Stock Holding History

PDT Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-82,740
Closed -$2.97M – 712
2022
Q3 		$2.97M Buy
82,740
+27,039
+49% +$953K 0.45% 22
2022
Q2 		$1.71M Buy
55,701
+24,424
+78% +$712K 0.15% 211
2022
Q1 		$1.01M Buy
+31,277
New +$819K 0.09% 367
2021
Q3 		– Sell
-14,214
Closed -$300K – 811
2021
Q2 		$300K Buy
+14,214
New +$285K 0.02% 616
2015
Q4 		– Sell
-12,603
Closed -$201K – 573
2015
Q3 		$201K Buy
+12,603
New +$246K ﹤0.01% 1157

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

PDT Partners's EVH Position: Q4 2022 in Review

PDT Partners sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 82,740 shares — an estimated $2.97M sold.

PDT Partners first reported a position in EVH in Q3 2015 and held it in 5 quarters. The position peaked at $2.97M in Q3 2022. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • PDT Partners reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 82,740 Evolent Health shares in Q4 2022, an estimated $2.97M.
  • PDT Partners first reported a position in Evolent Health in Q3 2015 and held it in 5 quarters.
  • PDT Partners's Evolent Health position peaked at $2.97M in Q3 2022.
  • 232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.